Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 24.27% vs 4.59% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 131.58% vs -73.83% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 55.10% vs -34.67% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 100.00% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Enwei Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 28.29% vs -21.83% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 24.27% vs 4.59% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 34.97% vs 5.16% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 131.58% vs -73.83% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 34.28% vs -13.46% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 55.10% vs -34.67% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 0.00% vs -20.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 100.00% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






